In Ghana, the monthly cost of medication for Chronic Myeloid Leukemia (CML) is approximately GH₵34,000, or $3,000. This substantial financial burden is a significant challenge for most Ghanaian households, as it equates to about a year's income. Dr. Amma Benneh Akwasi-Kuma, a hematologist and Director of the West Africa Medicine Center at the University of Ghana College of Health Sciences, highlighted this issue while speaking at events marking World CML Awareness Day.
The high cost of CML medication is a major obstacle for patients in Ghana. However, the Max Foundation, a US-based charity, has been providing free CML medication to patients at Korle Bu Teaching Hospital since 2007. The organization also covers the cost of shipping the medication into the country. This support has been instrumental in keeping patients alive, as many would not be able to afford the treatment otherwise.
Despite the Max Foundation's efforts, bureaucratic delays in processing waivers for the medication at facilities outside Korle Bu can leave patients without treatment. Dr. Benneh recalled an instance where patients had to wait about five months for a waiver to be approved, resulting in a gap in their medication supply. She appealed to authorities to expedite such requests, emphasizing that the program is legitimate and that her team is ready to provide necessary documentation.
A patient who has been on CML medication for about 20 years shared her experience at the World CML Awareness Day event. She described her diagnosis as a turning point, after years of being misdiagnosed with malaria or other conditions. Since starting treatment, she has led a fulfilling life, completing graduate school, becoming a doctor, and eventually a professor. She attributed her positive outcome to the life-changing medication and encouraged other patients not to lose hope.
Dr. Benneh used the occasion to address the stigma associated with CML, urging Ghanaians to offer support to those living with the condition rather than isolating them. She emphasized that patients who feel supported are more likely to seek consistent care and manage their condition effectively. By reducing stigma and increasing awareness, Dr. Benneh hopes to improve the lives of CML patients in Ghana.
Chronic Myeloid Leukemia is a slow-growing cancer of the blood and bone marrow that causes the body to produce too many white blood cells. While it can be a manageable condition with daily oral medication, reliable access to the medication is crucial. Dr. Benneh's comments highlight the need for faster processing of medication waivers and greater public awareness to reduce stigma against CML patients.
The World CML Awareness Day event, themed "Together We Fight CML, More Awareness, Brighter Together," aimed to bring attention to the disease and its management in Ghana. As Dr. Benneh and other stakeholders continue to advocate for improved support and awareness, patients with CML in Ghana may look forward to better treatment outcomes and a reduced stigma associated with their condition.
Key points
- The monthly cost of CML medication in Ghana is approximately GH₵34,000, a significant financial burden for most households.
- The Max Foundation has been providing free CML medication to patients at Korle Bu Teaching Hospital since 2007.
- Bureaucratic delays in processing medication waivers can leave patients without treatment, emphasizing the need for expedited requests.
